Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? (Q36860053)

16 August 2017

1 reference

title

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? (English)

1 reference

16 August 2017

0 references

Charles H Large

1

1 reference

PubMed ID

17591656

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Journal of Psychopharmacology

16 August 2017

1 reference

16 August 2017

21

1 reference

16 August 2017

3

1 reference

16 August 2017

283-301

1 reference

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Low dose ketamine increases prepulse inhibition in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Phencyclidine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Observations on the psychotomimetic effects of Sernyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Interaction of stress and strain on glutamatergic neurotransmission: relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Prestimulus effects on human startle reflex in normals and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Carbamazepine maintenance treatment in outpatient schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Metabotropic glutamate receptors: potential drug targets for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The gamma band response may account for poor P50 suppression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dose response and dose equivalence of antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

A two-process theory of schizophrenia: evidence from studies in post-mortem brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Combined treatment of schizophrenic psychoses with haloperidol and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of phencyclidines on signal transfer from the entorhinal cortex to the hippocampus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Clinical and sensorimotor gating effects of ketamine in normals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Clozapine plus lamotrigine in treatment-resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Cortical excitability in neuroleptic-naive first-episode schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Phencyclidine and the midbrain dopamine system: electrophysiology and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Modern antipsychotic drugs: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Probing prefrontal function in schizophrenia with neuropsychological paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Genes for schizophrenia? Recent findings and their pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Gamma frequency-range abnormalities to auditory stimulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of ketamine in normal and schizophrenic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The potential role of lamotrigine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Gender differences and the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Identification of single-nucleotide polymorphisms in the human N-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

PCP: from pharmacology to modelling schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

New insights and new issues in developmental neurotoxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The effects of a sub-anaesthetic dose of ketamine on human selective attention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Information-processing deficits and thought disorder in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Prolonged psychosis attributed to phencyclidine: report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Selective cognitive impairments associated with NMDA receptor blockade in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dopamine agonist action of phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Strain-specificity in nicotine attenuation of phencyclidine-induced disruption of prepulse inhibition in mice: relevance to smoking in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Do epileptic seizures damage the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Diverse psychotomimetics act through a common signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Evaluating glutamatergic transmission in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

D-serine added to antipsychotics for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

How specific are deficits in mismatch negativity generation to schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Ketamine effects on eye movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Cell biology of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Antagonism of a PCP drug discrimination by hallucinogens and related drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

Glycine potentiates the NMDA response in cultured mouse brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077712

21 January 2018

Identifiers

DOI

10.1177/0269881107077712

1 reference

16 August 2017

1 reference

PubMed ID

17591656